Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorZhongshan People's Hospital, Guangdong, China

About this trial

Brief Summary: This randomized controlled trial aims to evaluate whether active remote symptom monitoring and management via a smartphone app utilizing electronic patient-reported outcomes (ePRO) can improve adherence to prescribed outpatient pulmonary rehabilitation exercises among postsurgical lung cancer patients. Eligible patients will use the app for perioperative care and be randomized to an intervention group receiving ePRO-based symptom monitoring with clinician feedback or a control group receiving ePRO without feedback. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. If proven effective, the app-enabled remote rehabilitation model can be scaled up to enhance recovery for more postoperative patients.

Due to slower-than-expected recruitment, an interim analysis was introduced through a protocol amendment. Before any unblinded between-group efficacy analysis, a blinded review of recruitment progress, data completeness, and outcome-data structure was conducted. Mean weekly exercise duration was subsequently added as a co-primary endpoint to complement the threshold-based exercise adherence outcome. The amendment and revised interim statistical framework were approved by the Ethics Committee before the formal interim analysis and incorporated into the updated study record.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18-75 years old

preoperative clinical diagnosis or suspicion of resectable primary lung cancer

Able to use smartphones and complete electronic questionnaires

Signed informed consent

Disqualifiers

conversions to open thoracotomy during surgery

ECOG score > 1

Received neoadjuvant therapy

Previous lung resection surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • ePRO based Remote Symptom Management provide by a mobile phone app

    Device

    Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management. This is facilitated through the "Shuyu" mobile application, which serves as the platform for monitoring symptoms and communication.

Treatment groups

736 Participants
are divided into 2 treatment groups
Group A: Intervention GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Rehabilitation exercise adherence rate over 1 month after discharge

Rehabilitation exercise adherence rate over 1 month after discharge, defined as the proportion of patients completing the prescribed outpatient exercise regimen.

Time frame
From the day of discharge to 30 days after discharge
2

Mean weekly exercise duration over 1 month after discharge

Mean weekly exercise duration measured over the first 30 days post-discharge. This endpoint was added through a protocol amendment before the formal unblinded interim efficacy analysis. Interim testing used a Lan-DeMets O'Brien-Fleming alpha-spending approach.

Time frame
From discharge to 30 days after discharge.

Secondary outcomes

1

Post-discharge pulmonary complication rate

Time frame
From the day of discharge to 30 days after discharge
2

30-day hospital readmission rate

Time frame
From the day of discharge to 30 days after discharge
3

Changes in symptom severity scores from discharge to 30 days

Time frame
From the day of discharge to 30 days after discharge
4

Patient satisfaction scores

Time frame
From the day of discharge to 30 days after discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.